Erratum to “Melatonin Suppresses the Expression of 45S Preribosomal RNA and Upstream Binding Factor and Enhances the Antitumor Activity of Puromycin in MDA-MB-231 Breast Cancer Cells”
Joint Authors
Sohn, Eun Jung
Kim, Bonglee
Jung, Ji-Hoon
Yun, Miyong
Shin, Eun Ah
Kim, Ji-Hyun
Park, Yong Koo
Lee, Duckgue
Lee, Hyo-Jeong
Kim, Sung-Hoon
Jung, Deok-Beom
Source
Evidence-Based Complementary and Alternative Medicine
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-07-21
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
In the article titled “Melatonin Suppresses the Expression of 45S Preribosomal RNA and Upstream Binding Factor and Enhances the Antitumor Activity of Puromycin in MDA-MB-231 Breast Cancer Cells” [1], there was an error in Figure 3(a), where the fifth lane (Mcl-1) was mistakenly duplicated with the sixth lane (Cyclin D1), due to a production error.
The correct figure is shown below.
American Psychological Association (APA)
Jung, Ji-Hoon& Sohn, Eun Jung& Shin, Eun Ah& Lee, Duckgue& Kim, Bonglee& Jung, Deok-Beom…[et al.]. 2019. Erratum to “Melatonin Suppresses the Expression of 45S Preribosomal RNA and Upstream Binding Factor and Enhances the Antitumor Activity of Puromycin in MDA-MB-231 Breast Cancer Cells”. Evidence-Based Complementary and Alternative Medicine،Vol. 2019, no. 2019, pp.1-2.
https://search.emarefa.net/detail/BIM-1150211
Modern Language Association (MLA)
Jung, Ji-Hoon…[et al.]. Erratum to “Melatonin Suppresses the Expression of 45S Preribosomal RNA and Upstream Binding Factor and Enhances the Antitumor Activity of Puromycin in MDA-MB-231 Breast Cancer Cells”. Evidence-Based Complementary and Alternative Medicine No. 2019 (2019), pp.1-2.
https://search.emarefa.net/detail/BIM-1150211
American Medical Association (AMA)
Jung, Ji-Hoon& Sohn, Eun Jung& Shin, Eun Ah& Lee, Duckgue& Kim, Bonglee& Jung, Deok-Beom…[et al.]. Erratum to “Melatonin Suppresses the Expression of 45S Preribosomal RNA and Upstream Binding Factor and Enhances the Antitumor Activity of Puromycin in MDA-MB-231 Breast Cancer Cells”. Evidence-Based Complementary and Alternative Medicine. 2019. Vol. 2019, no. 2019, pp.1-2.
https://search.emarefa.net/detail/BIM-1150211
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1150211
